ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adoptive Cell Therapy Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-35X13952
Home | Market Reports | Health| Nursing
Global Adoptive Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Adoptive Cell Therapy Market Insights, Forecast to 2030

Code: QYRE-Auto-35X13952
Report
December 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
JUNO
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
CELLECTIS
NantKwest Inc
SorrentoTherapeutics
Bellicum

Adoptive Cell Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Adoptive Cell Therapy Market

Adoptive Cell Therapy Market

Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
Market Analysis and Insights: Global Adoptive Cell Therapy Market
The global Adoptive Cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Adoptive Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Adoptive Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Adoptive Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adoptive Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Adoptive Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Adoptive Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Adoptive Cell Therapy Market Report

Report Metric Details
Report Name Adoptive Cell Therapy Market
CAGR 5%
Segment by Type
  • CAR-T
  • TCR-T
  • NK
  • TIL
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Adoptive Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adoptive Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adoptive Cell Therapy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Adoptive Cell Therapy Market report?

Ans: The main players in the Adoptive Cell Therapy Market are Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum

What are the Application segmentation covered in the Adoptive Cell Therapy Market report?

Ans: The Applications covered in the Adoptive Cell Therapy Market report are Lymphoma, Leukemia

What are the Type segmentation covered in the Adoptive Cell Therapy Market report?

Ans: The Types covered in the Adoptive Cell Therapy Market report are CAR-T, TCR-T, NK, TIL

Recommended Reports

Cell Therapy Markets

Cancer Therapies

Immunotherapy & Biologics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2019-2030)
2.2 Global Adoptive Cell Therapy Growth Trends by Region
2.2.1 Adoptive Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Adoptive Cell Therapy Market Dynamics
2.3.1 Adoptive Cell Therapy Industry Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Adoptive Cell Therapy by Players
3.1.1 Global Adoptive Cell Therapy Revenue by Players (2019-2024)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Adoptive Cell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2023
3.5 Global Key Players of Adoptive Cell Therapy Head office and Area Served
3.6 Global Key Players of Adoptive Cell Therapy, Product and Application
3.7 Global Key Players of Adoptive Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2019-2030)
6.2 North America Adoptive Cell Therapy Market Size by Type
6.2.1 North America Adoptive Cell Therapy Market Size by Type (2019-2024)
6.2.2 North America Adoptive Cell Therapy Market Size by Type (2025-2030)
6.2.3 North America Adoptive Cell Therapy Market Share by Type (2019-2030)
6.3 North America Adoptive Cell Therapy Market Size by Application
6.3.1 North America Adoptive Cell Therapy Market Size by Application (2019-2024)
6.3.2 North America Adoptive Cell Therapy Market Size by Application (2025-2030)
6.3.3 North America Adoptive Cell Therapy Market Share by Application (2019-2030)
6.4 North America Adoptive Cell Therapy Market Size by Country
6.4.1 North America Adoptive Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Adoptive Cell Therapy Market Size by Country (2019-2024)
6.4.3 North America Adoptive Cell Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2019-2030)
7.2 Europe Adoptive Cell Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2019-2024)
7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2025-2030)
7.2.3 Europe Adoptive Cell Therapy Market Share by Type (2019-2030)
7.3 Europe Adoptive Cell Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2019-2024)
7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2025-2030)
7.3.3 Europe Adoptive Cell Therapy Market Share by Application (2019-2030)
7.4 Europe Adoptive Cell Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2019-2024)
7.4.3 Europe Adoptive Cell Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Adoptive Cell Therapy Market Size (2019-2030)
8.2 China Adoptive Cell Therapy Market Size by Type
8.2.1 China Adoptive Cell Therapy Market Size by Type (2019-2024)
8.2.2 China Adoptive Cell Therapy Market Size by Type (2025-2030)
8.2.3 China Adoptive Cell Therapy Market Share by Type (2019-2030)
8.3 China Adoptive Cell Therapy Market Size by Application
8.3.1 China Adoptive Cell Therapy Market Size by Application (2019-2024)
8.3.2 China Adoptive Cell Therapy Market Size by Application (2025-2030)
8.3.3 China Adoptive Cell Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Adoptive Cell Therapy Market Size (2019-2030)
9.2 Asia Adoptive Cell Therapy Market Size by Type
9.2.1 Asia Adoptive Cell Therapy Market Size by Type (2019-2024)
9.2.2 Asia Adoptive Cell Therapy Market Size by Type (2025-2030)
9.2.3 Asia Adoptive Cell Therapy Market Share by Type (2019-2030)
9.3 Asia Adoptive Cell Therapy Market Size by Application
9.3.1 Asia Adoptive Cell Therapy Market Size by Application (2019-2024)
9.3.2 Asia Adoptive Cell Therapy Market Size by Application (2025-2030)
9.3.3 Asia Adoptive Cell Therapy Market Share by Application (2019-2030)
9.4 Asia Adoptive Cell Therapy Market Size by Region
9.4.1 Asia Adoptive Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Adoptive Cell Therapy Market Size by Region (2019-2024)
9.4.3 Asia Adoptive Cell Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2019-2024)
11.1.5 Novartis Recent Developments
11.2 Juno
11.2.1 Juno Company Details
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2019-2024)
11.2.5 Juno Recent Developments
11.3 Kite
11.3.1 Kite Company Details
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2019-2024)
11.3.5 Kite Recent Developments
11.4 Adaptimmune
11.4.1 Adaptimmune Company Details
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2019-2024)
11.4.5 Adaptimmune Recent Developments
11.5 Fibrocell
11.5.1 Fibrocell Company Details
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2019-2024)
11.5.5 Fibrocell Recent Developments
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Details
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2019-2024)
11.6.5 Lineage Cell Therapeutics Recent Developments
11.7 BioTime
11.7.1 BioTime Company Details
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2019-2024)
11.7.5 BioTime Recent Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Details
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2019-2024)
11.8.5 Vericel Corporation Recent Developments
11.9 Regeneus
11.9.1 Regeneus Company Details
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2019-2024)
11.9.5 Regeneus Recent Developments
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Details
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2019-2024)
11.10.5 Anhui Anke Biotechnology Recent Developments
11.11 Cellectis
11.11.1 Cellectis Company Details
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2019-2024)
11.11.5 Cellectis Recent Developments
11.12 NantKwest
11.12.1 NantKwest Company Details
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2019-2024)
11.12.5 NantKwest Recent Developments
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Details
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2019-2024)
11.13.5 SorrentoTherapeutics Recent Developments
11.14 Bellicum
11.14.1 Bellicum Company Details
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2019-2024)
11.14.5 Bellicum Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Novartis
JUNO
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
CELLECTIS
NantKwest Inc
SorrentoTherapeutics
Bellicum
List of Tables
    Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of CAR-T
    Table 3. Key Players of TCR-T
    Table 4. Key Players of NK
    Table 5. Key Players of TIL
    Table 6. Global Adoptive Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Adoptive Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Adoptive Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Adoptive Cell Therapy Market Share by Region (2019-2024)
    Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Adoptive Cell Therapy Market Share by Region (2025-2030)
    Table 12. Adoptive Cell Therapy Market Trends
    Table 13. Adoptive Cell Therapy Market Drivers
    Table 14. Adoptive Cell Therapy Market Challenges
    Table 15. Adoptive Cell Therapy Market Restraints
    Table 16. Global Adoptive Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Adoptive Cell Therapy Revenue Share by Players (2019-2024)
    Table 18. Global Top Adoptive Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2023)
    Table 19. Global Adoptive Cell Therapy Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Adoptive Cell Therapy, Headquarters and Area Served
    Table 22. Global Key Players of Adoptive Cell Therapy, Product and Application
    Table 23. Global Key Players of Adoptive Cell Therapy, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2019-2024)
    Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2025-2030)
    Table 29. Global Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Adoptive Cell Therapy Revenue Share by Application (2019-2024)
    Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Adoptive Cell Therapy Revenue Share by Application (2025-2030)
    Table 33. North America Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Adoptive Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Adoptive Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Adoptive Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Adoptive Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Adoptive Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Adoptive Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Adoptive Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Adoptive Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Adoptive Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Adoptive Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Adoptive Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Adoptive Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Adoptive Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Adoptive Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Novartis Company Details
    Table 66. Novartis Business Overview
    Table 67. Novartis Adoptive Cell Therapy Product
    Table 68. Novartis Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 69. Novartis Recent Developments
    Table 70. Juno Company Details
    Table 71. Juno Business Overview
    Table 72. Juno Adoptive Cell Therapy Product
    Table 73. Juno Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 74. Juno Recent Developments
    Table 75. Kite Company Details
    Table 76. Kite Business Overview
    Table 77. Kite Adoptive Cell Therapy Product
    Table 78. Kite Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 79. Kite Recent Developments
    Table 80. Adaptimmune Company Details
    Table 81. Adaptimmune Business Overview
    Table 82. Adaptimmune Adoptive Cell Therapy Product
    Table 83. Adaptimmune Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 84. Adaptimmune Recent Developments
    Table 85. Fibrocell Company Details
    Table 86. Fibrocell Business Overview
    Table 87. Fibrocell Adoptive Cell Therapy Product
    Table 88. Fibrocell Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 89. Fibrocell Recent Developments
    Table 90. Lineage Cell Therapeutics Company Details
    Table 91. Lineage Cell Therapeutics Business Overview
    Table 92. Lineage Cell Therapeutics Adoptive Cell Therapy Product
    Table 93. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 94. Lineage Cell Therapeutics Recent Developments
    Table 95. BioTime Company Details
    Table 96. BioTime Business Overview
    Table 97. BioTime Adoptive Cell Therapy Product
    Table 98. BioTime Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 99. BioTime Recent Developments
    Table 100. Vericel Corporation Company Details
    Table 101. Vericel Corporation Business Overview
    Table 102. Vericel Corporation Adoptive Cell Therapy Product
    Table 103. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 104. Vericel Corporation Recent Developments
    Table 105. Regeneus Company Details
    Table 106. Regeneus Business Overview
    Table 107. Regeneus Adoptive Cell Therapy Product
    Table 108. Regeneus Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 109. Regeneus Recent Developments
    Table 110. Anhui Anke Biotechnology Company Details
    Table 111. Anhui Anke Biotechnology Business Overview
    Table 112. Anhui Anke Biotechnology Adoptive Cell Therapy Product
    Table 113. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 114. Anhui Anke Biotechnology Recent Developments
    Table 115. Cellectis Company Details
    Table 116. Cellectis Business Overview
    Table 117. Cellectis Adoptive Cell Therapy Product
    Table 118. Cellectis Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 119. Cellectis Recent Developments
    Table 120. NantKwest Company Details
    Table 121. NantKwest Business Overview
    Table 122. NantKwest Adoptive Cell Therapy Product
    Table 123. NantKwest Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 124. NantKwest Recent Developments
    Table 125. SorrentoTherapeutics Company Details
    Table 126. SorrentoTherapeutics Business Overview
    Table 127. SorrentoTherapeutics Adoptive Cell Therapy Product
    Table 128. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 129. SorrentoTherapeutics Recent Developments
    Table 130. Bellicum Company Details
    Table 131. Bellicum Business Overview
    Table 132. Bellicum Adoptive Cell Therapy Product
    Table 133. Bellicum Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)
    Table 134. Bellicum Recent Developments
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Adoptive Cell Therapy Market Share by Type: 2023 VS 2030
    Figure 3. CAR-T Features
    Figure 4. TCR-T Features
    Figure 5. NK Features
    Figure 6. TIL Features
    Figure 7. Global Adoptive Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Adoptive Cell Therapy Market Share by Application: 2023 VS 2030
    Figure 9. Lymphoma Case Studies
    Figure 10. Leukemia Case Studies
    Figure 11. Adoptive Cell Therapy Report Years Considered
    Figure 12. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Adoptive Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Adoptive Cell Therapy Market Share by Region: 2023 VS 2030
    Figure 15. Global Adoptive Cell Therapy Market Share by Players in 2023
    Figure 16. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2023
    Figure 18. North America Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Adoptive Cell Therapy Market Share by Type (2019-2030)
    Figure 20. North America Adoptive Cell Therapy Market Share by Application (2019-2030)
    Figure 21. North America Adoptive Cell Therapy Market Share by Country (2019-2030)
    Figure 22. United States Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Adoptive Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Adoptive Cell Therapy Market Share by Type (2019-2030)
    Figure 26. Europe Adoptive Cell Therapy Market Share by Application (2019-2030)
    Figure 27. Europe Adoptive Cell Therapy Market Share by Country (2019-2030)
    Figure 28. Germany Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Adoptive Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Adoptive Cell Therapy Market Share by Type (2019-2030)
    Figure 36. China Adoptive Cell Therapy Market Share by Application (2019-2030)
    Figure 37. Asia Adoptive Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Adoptive Cell Therapy Market Share by Type (2019-2030)
    Figure 39. Asia Adoptive Cell Therapy Market Share by Application (2019-2030)
    Figure 40. Asia Adoptive Cell Therapy Market Share by Region (2019-2030)
    Figure 41. Japan Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Adoptive Cell Therapy Market Share by Country (2019-2030)
    Figure 51. Brazil Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 58. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 59. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 60. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 61. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 62. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 63. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 64. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 65. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 66. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 67. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 68. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 69. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 70. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Cell Therapy Market Insights Forecast to 2030
Global Adoptive Cell Transfer Therapy Market Research Report 2024
Global Cell Transplantatio Therapy Market Insights Forecast to 2030
Global NK Cell Therapy Market Insights Forecast to 2030
Global Immuno Cell Therapy Market Research Report 2024
Global Stem Cell Therapy Market Insights Forecast to 2030
Global T Cell Immunotherapy Market Research Report 2025
Global Immunocell Therapy Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Immuno oncology Therapy Market Insights Forecast to 2030
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cellular Therapy CT Market Insights Forecast to 2030
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global Adoptive Cellular ImmunOthersapy Market Research Report 2024
Global Cytotherapy Market Insights Forecast to 2030
Global Autologous Cell Therapy Market Insights Forecast to 2030
Global CAR T Cell Immunotherapy Market Insights Forecast to 2030
Global Cell Based Immunotherapy Market Research Report 2024
Global Cell Immunotherapy Platform Market Research Report 2024

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions